Approximately 48% of organizations in the healthcare and pharma sectors plan to integrate their first generative artificial intelligence solution within one year. While 28% of the firms have already implemented AI technology in their business...

Real-world evidence (RWE) allows for the inclusion of a wide spectrum of patients, indicative of real-world clinical settings. This diversity has enhanced the understanding of how drugs perform across various demographics and clinical subgroups, p...

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has achieved yet another landmark in the history of generic drugs and sold medicines worth 1000 Crore INR last year...

In addition to traditional partnerships, embracing digital platforms and e-commerce can be a game-changer. Creating user-friendly online platforms for ordering and managing pharmaceutical supplies can streamline the distribution process, making it...

In an effort to seek a one-time exemption from the price control measures related to the declining WPI, the Indian Pharmaceutical Industry aims to put forward a request to India's drug pricing authority...

AI applications had made huge leap in medicine including drug discovery and personalized treatment options. By the proper integration of AI technology in personalized data collection and analysis, experts are expecting to find a quicker way to diagn